Nymox Pharmaceutical Corp (NYMX)
NASDAQ
The current NYMX market cap is 18.1M. The company's latest EPS is USD -0.0727 and P/E is -2.75.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 9k | 0 | 0 | 0 | 0 |
Operating Income | -1.48M | 1.68M | -1.39M | -1.1M | -1.01M |
Net Income | -1.49M | -1.34M | -1.39M | -1.11M | -1.04M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 299k | 116k | 5k | 0 | 0 |
Operating Income | -10.64M | -13.33M | -11.72M | -12.5M | -6.65M |
Net Income | -10.59M | -13.16M | -11.74M | -12.54M | -6.58M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.14M | 1.63M | 575k | 271k | 669k |
Total Liabilities | 2.37M | 2.11M | 2.37M | 3.15M | 2.57M |
Total Equity | 773k | -482k | -1.8M | -2.88M | -1.9M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 8.08M | 5.49M | 4.34M | 1.44M | 1.63M |
Total Liabilities | 1.07M | 2.04M | 2.2M | 1.95M | 2.11M |
Total Equity | 7M | 3.45M | 2.15M | -506k | -482k |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.96M | -5.21M | -988k | -1.9M | -3.16M |
Investing | N/A | N/A | -3k | -3k | -3k |
Financing | 5.83M | 5.78M | -61k | 629k | 1.84M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -7.8M | -7.43M | -10.04M | -9.82M | -5.21M |
Investing | -36k | N/A | -13k | -6k | N/A |
Financing | 14.93M | 4.72M | 8.42M | 7.05M | 5.78M |
Market Cap | 18.1M |
Price to Earnings Ratio | -2.75 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 12.9 |
Price to Book Ratio | -37.56 |
Dividend Yield | - |
Shares Outstanding | 90.52M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 0.00% |
52 Week High | 0.20 |
52 Week Low | 0.20 |
Spread (Intraday) | 0.02 (7.65%) |
Company Name | Nymox Pharmaceutical Corp |
Address |
bay & deveaux sts., 2nd floor nassau H4M 2V2 |
Website | https://www.nymox.com |
Industry | chemicals & chem preps, nec (2899) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.